Use of Alemtuzumab (Campath-1H) as Induction Therapy in Pediatric Kidney Transplantation

Transplantation Proceedings

Volumn 40, Issue 7, 2008, Pages 2226-2229

  Ona, E T ^a   Danguilan, R A ^a   Africa, J ^a   Cabanayan Casasola, C B ^a   Antonio, Z L ^a   Gutierrez Marbella, M A ^a   dela Cruz, R ^a   Bumanglag, N ^a   Espedilla, M E ^a  

^a National Kidney and Transplant Institute Philippines   (Philippines)

Author keywords

[No Author keywords available]

Indexed keywords

ALEMTUZUMAB; ANTIBIOTIC AGENT; CALCINEURIN INHIBITOR; COTRIMOXAZOLE; CYCLOSPORIN; DIPHENHYDRAMINE; ISONIAZID; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NYSTATIN; PARACETAMOL; RAPAMYCIN; TACROLIMUS; VALACICLOVIR;

ACUTE GRAFT REJECTION; ADOLESCENT; ARTICLE; CHRONIC ALLOGRAFT NEPHROPATHY; COLITIS; CONTROLLED STUDY; CREATININE BLOOD LEVEL; FEMALE; GLOMERULONEPHRITIS; HUMAN; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; INFECTION; INJECTION SITE REACTION; KIDNEY TRANSPLANTATION; MALE; PREMEDICATION; PRIORITY JOURNAL; SCHOOL CHILD; SEPSIS;

ADOLESCENT; ANTIBODIES, MONOCLONAL; ANTIBODIES, NEOPLASM; CHILD; CREATININE; FEMALE; GRAFT REJECTION; HISTOCOMPATIBILITY TESTING; HUMANS; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; MALE; NEUTROPENIA;

EID: 51249094728     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2008.07.050     Document Type: Article

References (15)

1. Smith J.M., Ho P.L.M., and McDonald R.A. Renal transplant outcomes in adolescents: a report of the North American Pediatric Renal Transplant Cooperative Study. Pediat Transplant 6 (2002) 493
2. Calne R., Moffat S.D., Friend P.J., et al. Campath-1H allows low-dose cyclosporine monotherapy in 31 cadaveric renal allograft recipients. Transplantation 68 (1999) 1613
3. Knechtle S.J., Fernandez L.A., Pirsch J.D., et al. Campath-1H in renal transplantation: the University of Wisconsin experience. Surgery 136 (2004) 754
4. Ciancio G., Burke G.W., Gaynor J.J., et al. The use of Campath-1H as induction therapy in renal transplantation: preliminary results. Transplantation August 78 (2004) 426
5. Watson C.J., Firth J., Bradley J.A., et al. Campath-1H (alemtuzumab) in renal transplantation: a 5-year comparative follow-up. Am J Transplant 4 (2004) 404 (Abstract No. 900)
6. Watson C.J., Bradley J.A., Friend P.J., et al. Alemtuzumab (Campath-1H) induction therapy in cadaveric kidney transplantation-efficacy and safety at 5 years. Am J Transplantation 5 (2005) 1347
7. Vathsala A., Ona E.T., Tan S.Y., et al. CampAsia: a pilot randomized, controlled trial of the effectiveness of Campath-1H (MabCampath) as an induction agent for the prevention of graft rejection and preservation of renal function in patients receiving kidney transplants. Am J Transplant 4 (2004) 406 (Abstract No. 908)
8. Ciancio G., Burke G.W., Gaynor J.J., et al. A randomized trial of three renal transplant induction antibodies: early comparison of tacrolimus, mycophenolate mofetil and steroid dosing, and newer immune-monitoring. Transplantation 80 (2005) 457
9. Knechtle S.J., Pirsch J.D., Fechner J., et al. Campath-1H as induction plus rapamycin monotherapy for renal transplantation: results of a pilot study. Am J Transplant 3 (2003) 722
10. Thomas P.G., Woodside K.J., Lappin J.A., et al. Alemtuzumab (Campath 1H) induction with tacrolimus monotherapy is safe for high immunological risk renal transplantation. Transplantation 83 (2007) 1509
11. Kaufman D.B., Leventhal J.R., Axelrod D., et al. Alemtuzumab induction and prednisone-free maintenance immunotherapy in kidney transplantation: comparison with basiliximab induction-long term results. Am J Transplant 5 (2005) 2539
12. Tzakis A.G., Kato T., Nishida S., et al. Preliminary experience with Campath 1H in intestinal and liver transplantation. Transplantation 75 (2003) 1227
13. Bartosh S.M., Knechtle S.J., and Sollinger H.W. Campath-1H use in pediatric renal transplantation. Am J Transplant 5 (2005) 1569
14. Tan H.P., Ellis D., Moritz M., et al. Pediatric living donor renal transplantation using alemtuzumab induction and tacrolimus monotherapy. Pediatr Transplant 11 (2007) 37
15. Bartosh S.M., Sanchez C.P., Sollinger H.W., et al. Pilot trial of steroid free immunosuppression in low-risk pediatric kidney transplants. Pediatr Transplant 11 (2007) 37